Physician profile
Stewart A Weber
NPI 1609118009
$19,283.49
in general payments reported to CMS, 2019-2025
13 companies · $2,350 in 2025
The $2,350 reported for 2025 was more than what 81% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,667 · 2020: $283 · 2021: $2,162 · 2022: $1,353 · 2023: $1,744 · 2024: $1,725 · 2025: $2,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,323 · Travel and Lodging: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,323.37 |
| Travel and Lodging | $495.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,087.79 | 2019-2025 | Surpass Evolve, Target, Axs Vecta 71 |
| Medtronic USA, INC. | $4,726.47 | 2019 | |
| Medical Device Business Services, INC. | $4,121.43 | 2019-2021 | |
| Microvention, INC. | $1,086.43 | 2019-2024 | Web Aneurysm Embolization System, Stent, Hydrosoft Advanced |
| Medtronic, INC. | $723.32 | 2021-2022 | |
| Penumbra, INC. | $454.93 | 2022-2025 | Penumbra System, Benchmark, Indigo System |
| Depuy Synthes Sales INC. | $372.06 | 2019-2022 | |
| Boston Scientific Corporation | $338.53 | 2021 | |
| Route 92 Medical, INC. | $293.87 | 2025 | |
| Cordis US Corp. | $20.06 | 2025 | Mynx Control Venous |
| Shockwave Medical, INC | $20.00 | 2025 | |
| Siemens Medical Solutions USA, INC. | $19.40 | 2021 | |
| Phenox INC. | $19.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stewart Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.